-
Interrogating LRRK2 Variants Common in Asian Populations to Discover Unique Biomarkers for Parkinson’s Disease
… Study Rationale: Mutations in the LRRK2 gene are the most common genetic cause of Parkinson's disease (PD). Many … the LRRK2 G2019S mutation found in Caucasians, and less is known about the LRRK2 variants that occur more frequently in … the LRRK2 kinase in these samples and explore whether, and how, these variants influence the immune system, the …
-
Michael J. Fox Foundation Awards $1 Million for Development of "Trojan Horse" Delivery Technology to Treat Parkinson’s Disease
August 15, 2008
… NEWYORK, NY — As part of its mission to drive transformative treatments and a cure for … Some of the therapeutic approaches that currently show the most promise to yield transformative treatments for … October.) Building on earlier work funded by MJFF under its Community Fast Track initiative, the ArmaGen team, led by …
-
PD Avengers Take Over MJFF’s Podcast to Help You Meet Parkinson’s Organizations around the World
August 25, 2021
… (MJFF) podcast for a special two-part episode , airing today, August 25 (part one), and Wednesday, September 1 … wellness, advocacy and research. The power of the PD community cannot be understated. As Michael J. Fox has said: … and it will be — it will be because of all of us, working together.” Tune in to the podcast (on iTunes or through any …
-
Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
November 29, 2007
… NY— In keeping with The Michael J. Fox Foundation’s mission to accelerate scientific breakthroughs that can transform … trial design and regulatory issues, is as efficient and targeted as possible. She will also provide important feedback … issues in mind. “Irene’s clinical research perspective complements the scientific expertise of Gene Johnson, PhD, …
-
The Latest from Capitol Hill: HEALTHY BRAINS Act Aims to Better Understand Environmental Risk Factors for Neurodegenerative Diseases
August 23, 2024
… policy at The Michael J. Fox Foundation; Rep. Jennifer Wexton (D-VA); Kristophe Diaz, executive director of CurePSP; … and Wexton for continuing to champion the Parkinson’s community with the introduction of the HEALTHY BRAINS Act. … to Parkinson’s: Environmental Connections to the Disease How Can You Help Advocate for the HEALTHY BRAINS Act? Use …
-
Michael J. Fox Foundation and Sanofi Launch Clinical Trial for Drug to Treat Parkinson’s-Related Cognitive Decline
January 21, 2013
… out how safe the drug is for those on PD drug regimens. The launch also marks the first time that the Foundation has … drug development for cognitive decline is that little is known about the underlying disease processes taking place in … To learn more about this trial and to connect with a trial site to explore participating, visit MJFF’s clinical trial …